ClinicalTrials.gg
Drug

Botulinum Toxins clinical trials

Also written Botulinum toxin.

A group of medicines. Botulinum toxin type A (820 studies) is counted on its own page; this page counts the studies that name Botulinum Toxins itself.

studies test it
64
open now
8
in phase 3
14
first study started
2001

How each study uses Botulinum Toxins is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Botulinum Toxins studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorisations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Botulinum toxin injection
12
Botox
12
Botulinum Toxins
6
Dysport
3
BTXa
2

Other names

Botulinum toxin
38
Botulinum Neurotoxin
2

Medicines filed under Botulinum Toxins

As reviewed, so not every one. Each counts its studies on its own page, not here.

Studies by the year they started

64 studies that test it; most in 2014 (8)

Studies that test Botulinum Toxins, by start year
YearStudies
20011
20031
20054
20071
20093
20101
20111
20124
20136
20148
20152
20165
20181
20194
20205
20212
20224
20233
20244
20253
20261

By phase

A phase 1/2 study counts in both.

Phase 1
11
Phase 2
20
Phase 3
14
Phase 4
11
No phase
16

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 4 · Other 60

Meshalkin Research Institute of Pathology of Circulation (5) · Galderma R&D (4) · Assistance Publique - Hôpitaux de Paris (3) · Henry Ford Health System (2) · National Institute of Neurological Disorders and Stroke (NINDS) (2) · University of Miami (2) · Centre Hospitalier Universitaire de Nice (1) · Antony Barbosa Institute (1)

Often tested with

Tested in the same studies.

Injection Route of Administration (1) · Adrenal Cortex Hormones (1) · Amlodipine (1) · Insulin (1) · Triamcinolone Acetonide (1) · Triamcinolone (1) · Bupivacaine (1) · Botulinum toxin type A (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 4, 2 in phase 3

Studies that test Botulinum Toxins, phase 3 first.

Studies

Open first, then newest update. How each study uses Botulinum Toxins is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 64

See all 64 studies that test Botulinum Toxins →

Given beside what is tested · 4 — Botulinum Toxins is usual care or a partner of the new treatment
As the comparator · 3 — what is tested is compared with Botulinum Toxins

What changed recently

From the registry's own updates since Oct 16, 2026.

Codes

What other systems call Botulinum Toxins · ClinicalTrials.gg INT007085

  • MeSH (NLM) D001905Botulinum ToxinsOne source ClinicalTrials.gov

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.